Perceptive Informatics survey highlights CTMS usage; FDA takes stance on clinical data submissions;

> Perceptive Informatics, an eClinical software provider and subsidiary of Parexel International ($PRXL), reports that its survey during a webinar found that 89 percent of respondents from the life sciences industry give their clinical research associates (CRAs) access to a clinical trial management system (CTMS) or other monitoring tool. "As site management is a key part of the CRA role, providing CRAs with access to the cross-study and cross-site data available within a CTMS is vital," Liz Love, product manager of CTMS at Perceptive Informatics, said in a press release. Release

> Seeking Alpha profiled eResearch Technology ($ERT), a Philadelphia-based firm that provides a range of data-related technology and services for life sciences companies developing new products. Report

> NVIDIA ($NVDA) says that it has released a its latest GPU (graphics processing unit) processor, the Tesla M2090. The Santa Clara, CA, firm, which serves many life sciences companies, says that its GPU processor proved faster than previous processors in a scientific computation test. NVIDIA release

> BioClinica ($BIOC), a Newtown, PA-based provider of software for clinical trials, has a recent blog post about the FDA's apparent frustration with companies not submitting data under CDISC SDTM standards correctly. Item

> Genetic Engineering & Biotechnology News has an article about how cloud computing has advanced to meet the needs of life sciences companies, but there are still some security concerns with the technology. Article